Drug Use clinical trials

Explore recruiting drug use clinical trials.

Recruiting drug use studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Drug Use trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Leveraging the neural mechanisms of social reward for drug relapse prevention

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Leveraging the neural mechanisms of social reward for drug relapse prevention

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Suboxone (buprenorphine/naloxone) versus methadone opioid rotation in patients with escalated opioid use and chronic pain: a randomized trial (SUMO study).

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Pilot study on the safety and feasibility of intravenous opioid agonist therapy (OAT) with Hydagelan® (hydromorphone hydrochloride) in Vienna.

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine?

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of the efficacy of sphenopalatine block in headache in patients with non-traumatic subarachnoid hemorrhage (SAH) after training of neurosurgical intensive care nurses.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Drug Use trials by city

Drug Use in Toronto Drug Use in Vancouver Drug Use in Montreal Drug Use in Calgary Drug Use in Edmonton Drug Use in Ottawa Drug Use in Winnipeg Drug Use in Quebec City Drug Use in Hamilton Drug Use in Kitchener Drug Use in London Drug Use in Halifax Drug Use in New York Drug Use in Los Angeles Drug Use in Chicago Drug Use in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease